McKinnon discusses ‘white space’ in R&D, about integrating generative and agentic AI with human-in-the-loop oversight while ...

Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...

Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company pioneering precision medicines that modulate regulatory ...

Extension financing adds new investors, Janus Henderson Investors and RA Capital, with strong renewed participation ...

Extensive peer-reviewed research has identified biologically active nutrients and biochemical intermediates that play ...

Astellas Pharma and AstraZeneca are joining Bristol Myers Squibb by deploying Evinova’s artificial-intelligence-native platform in an effort to speed up clinical development.

When working with investors, it is important to consider how your clinical development strategy and trials design align with investment priorities. Investors are interested in optimizing time, cost ...

T Biosciences, an immunotherapy company changing the future of treatment for solid tumors and other immune-mediated diseases, ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Science Exchange, the leading SaaS provider of supplier orchestration solutions for the life sciences industry, today announced the launch of its Clinical ...

Peter Greenleaf, President, CEO & Director, opened the call announcing "strong LUPKYNIS sales in 2025, growing at a rate of 25% year-over-year" and provided 2026 sales expectations for LUPKYNIS of ...

Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...